Tamoxifen for Breast Cancer Risk
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to learn whether a shorter-duration, low-dose tamoxifen regimen can reduce the risk of developing breast cancer or breast cancer recurrence in post-menopausal women who are at increased risk for breast cancer.
Who Is on the Research Team?
Mridula George, MD
Principal Investigator
Rutgers Cancer Institute
Are You a Good Fit for This Trial?
This trial is for post-menopausal women who have a higher risk of developing breast cancer or having it come back. Specific inclusion and exclusion criteria are not listed, but participants must be at increased risk for breast cancer.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Tamoxifen
Trial Overview
The study is testing if taking tamoxifen (Nolvadex) at a lower dose and for a shorter time can help prevent breast cancer or its return in high-risk women. Different durations of treatment will be compared.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.